| Cat# | Product Name | Price |
|---|---|---|
| Kit-0060 | AGE-RAGE in vitro Binding Assay Kit | Inquiry |
| Kit-0061 | RAGE Reactive AGEs Assay Kit, Glyceraldehyde | Inquiry |
Advanced glycation end products (AGEs) are a group of compounds formed through a non-enzymatic reaction between reducing sugars and proteins, lipids, or nucleic acids. They are formed endogenously in the body during normal metabolism and also exogenously in foods that are cooked at high temperatures, such as grilled or fried foods. AGEs have been implicated in various chronic diseases and aging processes.
AGEs, also known as glycotoxins, are a diverse group of compounds that are formed through the Maillard reaction. This reaction occurs when reducing sugars react with amino acids or other nucleophilic groups in macromolecules, leading to the formation of cross-links and modifications in the structure and function of biomolecules. AGEs can be categorized into three main groups: fluorescent AGEs, non-fluorescent AGEs, and cross-linked AGEs. Examples of fluorescent AGEs include pentosidine and Nε-(carboxymethyl) lysine (CML), while examples of non-fluorescent AGEs include imidazolone and methylglyoxal-derived AGEs.
The biological activity of AGEs is diverse and can have both detrimental and physiological effects in the body. AGEs can accumulate in tissues over time and contribute to the progression of chronic diseases, such as diabetes, cardiovascular disease, neurodegenerative disorders, and renal complications. They can promote inflammation and oxidative stress through the activation of cellular receptors, such as the receptor for advanced glycation end products (RAGE), leading to the production of pro-inflammatory cytokines and reactive oxygen species. AGEs can also induce the cross-linking of extracellular matrix proteins, impairing tissue elasticity and function. Moreover, AGEs can modify enzymatic activity, receptor-ligand interactions, and intracellular signaling pathways, affecting cellular functions and contributing to age-related decline.
Detecting the activity of AGEs is crucial for understanding their role in various diseases and aging processes. Several methods are available for measuring AGE levels in biological samples. One commonly used method is enzyme-linked immunosorbent assay (ELISA), which detects specific AGE adducts using antibodies that recognize AGE-modified proteins. This method provides a quantitative measurement of AGE accumulation in tissues or body fluids. Another widely used technique is liquid chromatography-mass spectrometry (LC-MS), which enables the identification and quantification of different types of AGEs based on their mass and fragmentation patterns. LC-MS is highly sensitive and can provide detailed information about the chemical composition and structure of AGEs.
In addition to detecting AGE activity, it is important to understand their function and how they contribute to disease development. Several approaches have been developed to study the functional effects of AGEs in cells and tissues. Cell culture studies using AGE-modified proteins or synthetic AGEs can elucidate the cellular response to AGE exposure. These studies can assess the activation of inflammatory pathways, changes in gene expression, and alterations in cell viability and function. Animal models, such as diabetic rodents or transgenic mice, can also be used to investigate the impact of AGE accumulation on organ function and disease progression. These models can provide insights into the long-term effects of AGEs and the potential therapeutic interventions to mitigate their detrimental effects.
We are here to answer any question you may have